Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.190
+0.240 (8.14%)
At close: Dec 20, 2024, 4:00 PM
3.400
+0.210 (6.58%)
After-hours: Dec 20, 2024, 6:17 PM EST

Cyclerion Therapeutics Revenue

Cyclerion Therapeutics had revenue of $194.00K in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $194.00K.

Revenue (ttm)
$194.00K
Revenue Growth
n/a
P/S Ratio
41.05
Revenue / Employee
$194,000
Employees
1
Market Cap
8.07M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022297.00K-3.65M-92.47%
Dec 31, 20213.94M1.65M71.69%
Dec 31, 20202.30M-2.21M-49.06%
Dec 31, 20194.51M--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Meihua International Medical Technologies 94.25M
XWELL 33.83M
Precipio 17.41M
Dominari Holdings 12.59M
NeuroMetrix 3.77M
RedHill Biopharma 3.71M
Elevai Labs 2.45M
Revenue Rankings